Anti-GUCY2C (clone 5F9)-MMAE ADC

  • 1.00 Dollar US$
  • Published date: December 8, 2018
    • Shirley, New York, United States

This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9)conjugated via a Cleavable peptide linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-gucy2c-52.htm

Result 0 votes
Bella
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-GUCY2C (clone 5F9)-Mc-MMAF ADC

    Anti-GUCY2C (clone 5F9)-Mc-MMAF ADC

    Reagents - Supplies Shirley (New York) December 8, 2018 1.00 Dollar US$

    This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Reagents - Supplies Shirley (New York) December 8, 2018 1.00 Dollar US$

    This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-GPNMB-VC-MMAE ADC

    Anti-GPNMB-VC-MMAE ADC

    Reagents - Supplies Shirley (New York) December 8, 2018 1.00 Dollar US$

    This ADC product is comprised of an anti-GPNMB monoclonal antibody conjugated via a VC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MM...